F 0759
Ensure medication error rates are not 5 percent or greater.
Level of Harm - Minimal harm
or potential for actual harm
Based on observations, interviews, and record review, the facility failed to administer medications as
ordered for 1 (R93) of 5 residents reviewed during medication administration in the sample of 48. There
were 27 opportunities with two errors resulting in a 7.41% error rate.
Residents Affected - Few
Findings include:
On 08/12/24 at 09:22 AM Surveyor observed V11 (Licensed Practical Nurse) administering medications on
the second floor unit. Surveyor observed V11 (LPN) administering medications to R93.
On 08/12/2024 at 01:56 PM Surveyor noticed, while completing medication reconciliation, that V11 (LPN)
documented in R93's MAR (Medication Administrator Record) two medications as given whereas surveyor
did not observe those medications being given during medication administration task.
On 08/12/24 at 02:13 PM Surveyor interviewed V11 (LPN). Surveyor asked if V11 (LPN) gave all
medications to R93, V11 (LPN) said, R93 refused two. Surveyor asked if V11 (LPN) followed up with R93
and offered it again, V11 (LPN) said, I will do it right now. Surveyor established that V11 (LPN) signed out
both medications as given, V11 (LPN) said, I'm sorry, let me see if R93 wants them now. Surveyor asked
what should have been done this morning, upon R93's refusal, V11 (LPN) said, I should have documented
it as refused when R93 refused to take two of the medications this morning.
On 08/13/24 at 10:17 AM Surveyor interviewed V2 (Director of Nursing) who stated: If a resident refuses a
medication, nurse should re-offer the medication in a few minutes and try to find out why the resident
doesn't want to take it. The nurse should document the refusal and notify all involved parties, such as
doctor and resident representative. Surveyor clarified why is it inappropriate to document that medication
was given when, in fact, it was not, V2 (DON) said: The documentation is inaccurate if a nurse signs off
medication as it was given but, in fact, it was not given.
R93's physician order dated 11/27/2022 reads in part, Tiotropium Bromide Monohydrate Capsule 18 MCG
1 capsule inhale orally one time a day for COPD Rinse mouth with water and spit after administration due
at 9:00 AM
R93's physician order dated 11/27/2022 reads in part, Wixela Inhub Aerosol Powder Breath Activated
250-50 MCG/DOSE (Fluticasone- Salmeterol) 1 puff inhale orally every 12 hours related to Unspecified
Asthma. Rinse mouth with H2O and spit back in cup after use due at 9:00 AM and 9:00 PM
R93's MAR (Medication Administration Record) for August 2024 shows both, Tiotropium Bromide
Monohydrate Capsule and Wixela Inhub Aerosol Powder documented as given on 08/12/2024 at 9:00 AM
by V11 (LPN).
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 5
Event ID:
145171
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145171
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/14/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Elevate Care Northbrook
270 Skokie Highway
Northbrook, IL 60062
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0759
Level of Harm - Minimal harm
or potential for actual harm
The policy provided by the facility MAC Rx Pharmacy Policies and Procedures Manual dated 10/25/2024
reads in part, Refusals of Medications: 5) Medication refusal must be reported to the prescriber after (XX)
number of doses are refused and there must be documentation of prescriber notification of such.
Documentation (including electronic): 1) At the end of each medication pass, the person administering the
medications reviews the MAR to ensure necessary doses were administered and documented.
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145171
If continuation sheet
Page 2 of 5
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145171
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/14/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Elevate Care Northbrook
270 Skokie Highway
Northbrook, IL 60062
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted
professional principles; and all drugs and biologicals must be stored in locked compartments, separately
locked, compartments for controlled drugs.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review, the facility failed to follow their medication storage policy by not
ensuring an insulin vial was properly labeled and stored in accordance with accepted professional practice.
This failure affected 6 residents with orders for Lispro (Human) insulin (R97, R105, R124, R146, R187,
R193) of 6 residents reviewed for medication label and storage.
Findings include:
On [DATE] at 11:28 AM, reviewed medication storage and labeling task for 1 east med cart with V14
(Registered Nurse) and observed an opened and unlabeled vial of lispro insulin that was half filled. When
asked which resident the insulin vial belonged to, V14 (RN) said he did not know. When asked if the insulin
vial was currently being used and if the vial should be stored in the refrigerator when not in use, V14 (RN)
said yes. V14 (Registered Nurse) then said the insulin vial should have been properly labeled with the
resident's name, dated when opened with the date of expiration indicated to avoid staff administering
expired insulin to a resident.
Requested list of residents on unit 1 east who receive lispro insulin. V1 (Administrator) provided a list of
dated [DATE] that showed the following residents: R97, R105, R124, R146, R187, and R193. Active
physician orders reconciled with medication administration records for above listed residents that revealed
an active order for lispro that is being administered daily as follows:
1. R97's active physician orders showed order with start date of [DATE] for Humalog Solution 100 unit/ml
(Insulin Lispro (Human), inject subcutaneous (under the skin) five times a day for diabetes as per sliding
scale: if 0 - 69 = 0 Units Give glucose and notify physician; 70 - 149 = 0 Units; 150 - 199 = 1 Unit; 200 - 249
= 3 Units; 250 - 299 = 5 Units; 300 - 349 = 7 Units; 350 > give 8 units and notify physician.
Medication administration records for last 60 days (06/2024 through [DATE]) showed daily administrations
of lispro insulin for R97.
2. R105's active physician orders showed order with start date of [DATE] for Humalog Solution 100 unit/ml
(Insulin Lispro (Human), inject subcutaneous (under the skin) before meals for per clinical parameters
related to diabetes, inject as per sliding scale: if 0 - 69 = 0 Units Give glucose and notify physician; 70 - 149
= 0 Units; 150 - 199 = 1 Unit; 200 - 249 = 2 Units; 250 - 299 = 3 Units; 300 - 349 = 4 Units; 350 > give 5
units and notify physician.
Medication administration records for last 60 days (06/2024 through [DATE]) showed daily administrations
of lispro insulin for R105 as of start date of [DATE].
3. R124's active physician orders showed order with start date of [DATE] for Humalog Solution 100 unit/ml
(Insulin Lispro (Human), inject subcutaneous (under the skin) before meals and at bedtime, inject as per
sliding scale: if 150 - 199 = 1 units; 200 - 249 = 2 units ; 250 - 299 = 3 units; 300 - 349 = 4 units more or =
350 milligram (mg)/deciliter (dl) 5 units call primary medical doctor (PMD) for blood sugar (bs) more than
400 and call PMD. Less than 60 mg/dl call PMD.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145171
If continuation sheet
Page 3 of 5
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145171
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/14/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Elevate Care Northbrook
270 Skokie Highway
Northbrook, IL 60062
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Medication administration records for last 60 days (06/2024 through [DATE]) showed daily administrations
of lispro insulin for R124.
4. R146's active physician orders showed order with start date of [DATE] for Humalog Solution 100 unit/ml
(Insulin Lispro (Human), inject 3 units subcutaneous (under the skin) every 6 hours for diabetes.
Residents Affected - Some
Medication administration records for last 60 days (06/2024 through [DATE]) showed daily administrations
of lispro insulin for R146.
5. R187's active physician orders showed order with start date of [DATE] for Humalog Solution 100 unit/ml
(Insulin Lispro (Human), inject subcutaneous (under the skin) before meals and at bedtime for diabetes
AND Inject 3 unit subcutaneously before meals and at bedtime related to diabetes, inject as per sliding
scale: if 0 - 69 = 0 Units Give glucose and notify physician; 70 - 149 = 0 Units; 150 - 199 = 1 Unit; 200 - 249
= 2 Units; 250 - 299 = 3 Units; 300 - 349 = 4 Units; 350 > give 5 units and notify physician.
Medication administration records for last 60 days (06/2024 through [DATE]) showed daily administrations
of lispro insulin for R187 as of start date of [DATE].
6. R193's active physician orders showed order with start date of [DATE] for Insulin Lispro 100 unit/ml
solution, inject subcutaneous (under the skin) one time a day with meal related to type 2 diabetes mellitus,
inject as per sliding scale: if 150 - 199 = give 1 unit and notify physician; 200 - 249 = give 2 units; 250 - 299
= give 3 units; 300 - 349 = give 4 units; 350 > give 5 units and notify physician.
Medication administration records for last 60 days (06/2024 through [DATE]) showed daily administrations
of lispro insulin for R193 as of start date of [DATE].
*Noted R193's discontinued order on [DATE] for Insulin Lispro 100 unit/ml solution with start date of [DATE]
to inject subcutaneous (under the skin) before meals related to type 2 diabetes mellitus, inject as per sliding
scale: if 0 - 69 = give 0 units and notify physician; 70 - 149 = give 0 units; 150 - 199 = give 1 unit; 200 - 249
= give 2 units; 250 - 299 = give 3 units; 300 - 349 = give 4 units; 350> give 5 units and notify physician.
Medication administration records for last 60 days (06/2024 through [DATE]) showed daily administrations
of lispro insulin for R193 as of start date of [DATE]*
On [DATE] at 11:55 AM, V2 (Director of Nursing) said all insulin vials should be dated upon opening and
should include residents name and expiration date.
Medication storage policy last revised [DATE] reads in part: to ensure proper storage, labeling and
expiration dates of medications, biologicals, syringes and needles. Once any medication or biological
package in opened, facility should follow manufacturer/supplier guidelines with respect to expiration dates
for opened medications. Facility staff should record the date opened on the medication container when the
medication has a shortened expiration date once opened. Facility should destroy and reorder medications
and biologicals with soiled, illegible, worn, makeshift, incomplete, damaged or missing labels. Facility
should ensure that medications and biologicals are stored at their appropriate temperatures according to
United States Pharmacopeia guidelines for temperature ranges.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145171
If continuation sheet
Page 4 of 5
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145171
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/14/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Elevate Care Northbrook
270 Skokie Highway
Northbrook, IL 60062
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Vials and Ampules of Injectable Medications policy effective [DATE] reads in part: vials and ampules of
injectable medications are used in accordance with the manufacturer's recommendations or the provider
pharmacy's directions for storage, use, and disposal. The date opened and the initials of the first person to
use the vial are recorded on the multidose vials. Medication in multidose vials may be used until the
manufacturer's expiration date/for the length of time allowed by the state law/according to facility policy/ for
thirty days. USP <797> guidelines recommend discarding multidose vials at 28 days after opened.
Reviewed lispro manufacturer instructions for use after vials have been opened that indicated to store
opened vials in the refrigerator or at room temperature up to 86°F (30°C) for up to 28 days and
throw away all opened vials after 28 days of use, even if there is insulin left in the vial.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145171
If continuation sheet
Page 5 of 5